Get the Daily Brief
Latest Biotech News
Regulatory Shifts and Industry Financing Highlights
Significant industry movements include Sage Therapeutics planning layoffs of most staff following acquisition by Supernus Pharmaceuticals, underscoring volatility in neuropharma. Imagene AI raised...
Innovations in Gene Editing and RNA Therapeutics
Technological advances are accelerating gene and RNA-based therapies. Researchers demonstrated a near-infrared light activatable CRISPR system enabling precise spatiotemporal genome editing....
Single-Atom and Molecular Advances in Cancer Therapy
Cutting-edge cancer research highlights include the use of single-atom engineering to create radiotherapy-activated immune prodrugs that boost targeted immune responses. Studies revealed...
Climate Change and Environmental Impact on Health and Agriculture
New studies shed light on environmental challenges affecting health and food systems. Research revealed gut bacteria bioaccumulate harmful PFAS pollutants, presenting novel microbiome-targeted...
AbbVie Buys In Vivo CAR-T Developer Capstan for $2.1 Billion
AbbVie has announced a $2.1 billion acquisition of Capstan Therapeutics, a startup advancing in vivo CAR-T therapies aimed at autoimmune diseases and cancer. Capstan’s lead candidate CPTX2309, an...
Phase 2b Trial Shows Psychedelic Mebufotenin Cuts Depression Symptoms
Beckley Psytech and Atai Life Sciences reported positive Phase 2b trial results for BPL-003, an intranasal formulation of the psychedelic mebufotenin, significantly reducing symptoms in...
New Chemotherapy Mutational Signatures Reveal Long-Term Risks
A landmark study led by the Wellcome Sanger Institute and University of Cambridge has systematically characterized DNA damage patterns caused by various chemotherapy drugs in healthy blood cells....
Moderna’s mRNA Flu Vaccine Shows Superior Efficacy in Phase 3 Trial
Moderna announced that its mRNA-based seasonal influenza vaccine, mRNA-1010, demonstrated a 27% reduction in influenza-like illness compared to a standard marketed vaccine in individuals aged 50...
Machine Learning Models Enhance Cancer Detection and Prognosis
Recent advances in artificial intelligence have produced models capable of improving diagnosis and outcome prediction in oncology. This includes an AI platform for early pancreatic cancer...
Parkinson’s Disease Research Yields Molecular and Therapeutic Insights
Multiple studies reveal new understanding of Parkinson’s disease (PD) mechanisms and interventions. These include digital speech biomarkers measuring levodopa effects, enzyme inhibition restoring...
Advances in Sustainable and Biomedical Materials Science
Innovative research is increasing the ease and scope of creating sustainable biomaterials and medical textiles. Developments include cellulose-derived biodegradable foams, breathable protective...
Genetic and Molecular Targets Propel Cancer and Immunotherapy Research
Cutting-edge studies identify novel molecular mechanisms and therapeutic targets across cancer and immunology fields. Topics include DLK1 as an immunotherapy target in adrenocortical carcinoma,...
AI and Automation Transform Biotech Research and Clinical Workflows
Integration of AI, robotics, and automation is accelerating discoveries and clinical efficiency. Innovations include AI-powered enzyme engineering with autonomous labs, AI-based early PTSD...
AbbVie Bets Big on In Vivo CAR-T with $2.1 Billion Capstan Acquisition
AbbVie has announced a $2.1 billion acquisition of Capstan Therapeutics, marking a significant expansion into the in vivo CAR-T therapy arena. Capstan’s lead program, CPTX2309, a phase 1 anti-CD19...
Psychedelic Drug Advances Trigger Beckley-Atai Merger Plans
Beckley Psytech and Atai Life Sciences have announced positive Phase 2b results for their intranasal psychedelic drug, mebufotenin, demonstrating significant symptom reduction in...
AI and Machine Learning Transform Biomedical Research and Diagnostics
Artificial intelligence and machine learning continue to make landmark advances in biomedical applications. From university-led projects developing AI-powered leukemia-on-a-chip platforms to...
New Chemotherapy Mutation Signatures Inform Safer Cancer Treatments
Researchers from the Wellcome Sanger Institute, University of Cambridge, and Cambridge University Hospitals have uncovered novel DNA mutational signatures induced by various chemotherapy agents in...
Moderna’s mRNA Flu Vaccine Surpasses Expectations in Late-Stage Trial
Moderna reported compelling phase 3 results for its mRNA-based seasonal influenza vaccine, mRNA-1010, showing 26.6% greater efficacy in preventing influenza-like illness among adults aged 50 and...
Liver Cancer Prognostics Enhanced by New Biomarker and Machine Learning Insights
Innovative studies in hepatocellular carcinoma (HCC) have identified improved methods to predict patient outcomes. Research highlights include the discovery of prognostic power in...
Biotech Financing and Industry Leadership Shakeups Mark Market Activity
Recent weeks have seen significant venture capital movements and leadership changes within the biotech sector. Catalio Capital closed a $400 million Nexus Fund IV, enabling new startup launches...